CVE:LXG LexaGene (LXG) Stock Price, News & Analysis C$0.10 -0.03 (-19.23%) As of 02/21/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About LexaGene Stock (CVE:LXG) Get LexaGene alerts:Sign Up Key Stats Today's RangeC$0.10▼C$0.1450-Day RangeC$0.11▼C$0.1152-Week RangeC$0.07▼C$0.31Volume2.14 million shsAverage Volume170,061 shsMarket CapitalizationC$14.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts. Read More Receive LXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LXG Stock News HeadlinesPamapol Ord Share Price (0LXG)April 9, 2024 | lse.co.ukBiosynex SA ALBIONovember 12, 2023 | morningstar.comMThe SpaceX filing is public. The window is closing.SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.May 24 at 1:00 AM | Behind the Markets (Ad)Cyclopharm Ltd CYCOctober 31, 2023 | morningstar.comMLexagene Holdings Inc (LXGh)October 16, 2023 | investing.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliSeptember 2, 2023 | morningstar.comMZhejiang Gongdong Medical Technology Co Ltd Class AJuly 28, 2023 | morningstar.comMIIROC Trading Halt - LXGFebruary 22, 2023 | finance.yahoo.comSee More Headlines LXG Stock Analysis - Frequently Asked Questions How have LXG shares performed this year? LexaGene's stock was trading at C$0.11 at the beginning of 2026. Since then, LXG stock has increased by 0.0% and is now trading at C$0.11. How do I buy shares of LexaGene? Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of LexaGene own? Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT), Inovio Pharmaceuticals (INO) and NIO (NIO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCVE:LXG CIKN/A Webwww.lexagene.com Phone800-215-1824FaxN/AEmployees41Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$8.54 million Net MarginsN/A Pretax MarginN/A Return on Equity-339.54% Return on Assets-120.21% Debt Debt-to-Equity Ratio138.01 Current Ratio1.39 Quick Ratio1.13 Sales & Book Value Annual SalesC$110.93 thousand Price / Sales133.13 Cash FlowC$0.00 per share Price / Cash Flow21.25 Book ValueC$0.01 per share Price / Book10.50Miscellaneous Outstanding Shares140,640,000Free FloatN/AMarket CapC$14.77 million OptionableNot Optionable Beta2.26 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (CVE:LXG) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LexaGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
